TRIPLEX Study
A randomized phase III trial investigating the survival benefit of adding thoracic radiotherapy to durvalumab (MEDI4736) immunotherapy plus chemotherapy in extensive-stage small-cell lung cancer.
Learn more about TRIPLEXCurrent NTOG research activity
Ongoing projects belong on this page. Published trials and articles belong on the Publications page.
NTOG supports Nordic lung cancer research through collaborative academic studies, clinical trials, translational projects, registry-based research, and work-package activity.
This page lists selected active or developing projects. Details should be updated as public trial registrations, protocols, abstracts, or publications become available.
Current studies
Selected NTOG-linked studies with available public project material.
ACHILES Study
A randomized phase II study comparing atezolizumab after concurrent chemoradiotherapy with chemoradiotherapy alone in limited-disease small-cell lung cancer.
Learn more about ACHILESDeveloping studies
ADIL and DARTS are expected to be important upcoming NTOG studies.
ADIL
Upcoming NTOG study. Study category, participating countries, and public registration or protocol links will be added when available.
DARTS
Upcoming NTOG study. Study category, participating countries, and public registration or protocol links will be added when available.
These studies should stay on Ongoing Projects until public publications or formal published outputs are available.
Research routes
Explore published studies, collaboration routes, expert contacts, and the wider research overview.